Obstructive sleep apnea has been linked to an increased risk of dementia in a new study—and the association was particularly ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Researchers found that inhibiting the enzyme TYK2 may reduce the harmful accumulation of tau protein in Alzheimer’s disease, ...

Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall ...

The global neuromodulation device market will be worth $11.4bn by 2033, as per a market model from GlobalData.

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

As people age, the body changes as part of the normal ageing process, such as greying hair and loss of elasticity in the skin ...

In the last two years, two drugs have been federally approved to slow the onset of Alzheimer's disease in its early stages, ...

Trajectories of frailty increased more rapidly 4 to 9 years before dementia onset. Even before this acceleration, higher ...

For so long, we had a drought when it came to treatment options for Alzheimer's, until the last few years when we've seen two ...

Dementia is a condition that affects memory, thinking, and the ability to perform everyday tasks. As it progresses, it can ...